| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Dev. Officer | Chief Dev Operations Officer | EVP, Ww Development Operations
1 company
Frenkel Ran is an EVP, Chief Dev. Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Dev. Officer | Sell | 1,663 | $10.24 | $17,025.13 | -1.0% | -39.2% | -70.8% | |
| Feb 17, 2022 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Dev. Officer | Sell | 2,929 | $12.12 | $35,509.44 | -2.8% | -55.0% | -70.4% | |
| Feb 7, 2022 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Dev. Officer | Sell | 1,991 | $9.86 | $19,635.24 | -1.9% | -50.7% | -65.6% | |
| Feb 18, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Dev. Officer | Sell | 2,887 | $14.83 | $42,817.67 | -5.9% | - | - | |
| Feb 11, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Dev. Officer | Sale+OE | 2,046 | $15.52 | $31,751.87 | -4.9% | - | - | |
| May 7, 2020 | KPTI Karyopharm Therapeutics Inc. | Chief Dev Operations Officer | Sell | 1,974 | $20.00 | $39,480.00 | -5.3% | - | - | |
| Feb 19, 2020 | KPTI Karyopharm Therapeutics Inc. | Chief Dev Operations Officer | Sell | 2,975 | $16.48 | $49,033.65 | -7.6% | - | - | |
| Nov 7, 2017 | KPTI Karyopharm Therapeutics Inc. | Chief Dev Operations Officer | Sell | 4,958 | $11.25 | $55,755.19 | -16.7% | - | - | |
| Nov 14, 2016 | KPTI Karyopharm Therapeutics Inc. | Chief Dev Operations Officer | Sell | 3,309 | $10.06 | $33,286.22 | -18.4% | - | - | |
| Apr 7, 2015 | KPTI Karyopharm Therapeutics Inc. | EVP, Ww Development Operations | Buy | 3,000 | $31.81 | $95,430.00 | +300.0% | - | - |